HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,881,539 | +6.9% | 21,004 | +1.6% | 0.67% | +8.0% |
| Q2 2023 | $1,760,525 | +4.7% | 20,678 | +1.8% | 0.62% | -5.5% |
| Q1 2023 | $1,681,563 | -20.1% | 20,321 | -24.1% | 0.66% | -32.0% |
| Q4 2022 | $2,105,696 | +9.6% | 26,773 | +3.2% | 0.97% | +2.9% |
| Q3 2022 | $1,921,000 | +287.3% | 25,943 | +421.8% | 0.94% | +128.0% |
| Q1 2020 | $496,000 | -0.6% | 4,972 | +14.6% | 0.41% | +14.7% |
| Q4 2019 | $499,000 | +1.2% | 4,340 | +10.9% | 0.36% | -14.0% |
| Q3 2019 | $493,000 | +11.5% | 3,912 | +6.4% | 0.42% | +32.1% |
| Q2 2019 | $442,000 | +68.1% | 3,677 | +22.2% | 0.32% | +56.7% |
| Q1 2019 | $263,000 | +4.0% | 3,010 | +19.2% | 0.20% | -11.7% |
| Q4 2018 | $253,000 | -10.0% | 2,525 | +3.0% | 0.23% | +9.0% |
| Q3 2018 | $281,000 | +25.4% | 2,452 | -1.7% | 0.21% | +15.3% |
| Q2 2018 | $224,000 | – | 2,494 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |